CLINICAL_TRIALS
trial_result
· 2020-12-23
Clinical Trial Update: Confirmatory Study of DSP-5423P in Patients With Schizophrenia [Phase 3]
Summary
A Phase 3 confirmatory study of DSP-5423P in schizophrenia has completed and results were posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sumitomo Pharma Co., Ltd. | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2020-12-23